Methylation Analysis of Tumour Suppressor Genes in Ovarian Cancer Using MS-MLPA

作者：Chmelarova M^*; Krepinska E; Spacek J; Laco J; Nekvindova J; Palicka V

来源：Folia Biologica, 2012, 58(6): 246-250.

• MS-MLPA
• DNA methylation
• ovarian cancer
• CDH13
• epigenetics

Epigenetic changes are considered to be a frequent event during tumour development. Hyper-methylation of promoter CpG islands represents an alternative mechanism for inactivation of tumour suppressor genes, DNA repair genes, cell cycle regulators and transcription factors. The aim of this study was to investigate promoter methylation of specific genes in ovarian cancer by comparison with normal ovarian tissue. To search for epigenetic events we used methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA) to compare the methylation status of 69 tissue samples of ovarian cancer with 40 control samples. Using a 15% cut-off for methylation, we observed significantly higher methylation in genes MGMT, PAX5, CDH13, WT1, THBS1, GATA5 in the ovarian cancer group, while in the ESR1 gene we observed significantly higher methylation in the control group compared with the ovarian cancer group. These findings could potentially be used in screening of ovarian cancer and may have implications for future chemotherapy based on epigenetic changes.

• 出版日期2012